Skip to main content
. 2020 Dec 5;9(2):90–95. doi: 10.1016/j.prnil.2020.11.003

Table 2.

Reasons for termination of active surveillance

Termination of AS (n = 70)
Disease progression 30 (42.9)
Anxiety for active surveillance strategy 6 (8.6)
Follow-up loss 18 (25.7)
Expired due to other disease 7 (10.0)

Data are n (%).

AS, active surveillance.